"We have been working with Soar Beyond since 2016 to support the implementation of the practice pharmacist role in long term condition management through the i2i Network. The concept of the i2i programme focuses on supporting the practice-based pharmacist to implement in a standardised and structured way to improve patient care through educational workshops supported by a suite of online implementation resources. At the workshops, we witnessed a transformation of those who lacked confidence and a sense of direction, to an empowered and enthusiastic pharmacist feeling supported and keen to implement what they had learned to improve patient care. As a result of the continued success of the i2i Network type 2 diabetes programme, Napp has expanded its partnership to support the asthma programme. We were delighted to be acknowledged as a key partner by Soar Beyond when the i2i Network was a finalist in the 2018 HSJ ‘Improving outcomes through learning and development’ award. Our field and head office teams continue to work closely in partnership with Soar Beyond to support the roll out of the i2i Network locally."
"Soar Beyond were commissioned to undertake our 2015 and 2018 Pharmaceutical Needs Assessment due to their expertise, as well as their robust and thorough approach to document production. Throughout the process, Soar Beyond were proactive, flexible, responsive and committed to producing the highest quality PNA possible. The resulting documents have been very well received by our Health and Wellbeing Board."
“Soar Beyond has been delivering a ‘Core Group’ of advisors to us since 2013 and we continue to renew this service annually because we find the insights and the intelligence provided by this high calibre advisory group invaluable in shaping our services and product positioning. The Core Group comprises a cross-section of senior decision-makers (and national leaders) across primary and secondary care to simulate a real health economy and has evolved over the last five years to include STP and transformation personnel. This group meets three times a year but we also reach out to them to ask for advice in helping to shape our offerings and suggest key priorities for discussion at future Core Group meetings. This means that we are more connected and responsive to NHS priorities at a strategic-level and ensures that we are only investing in market access support that the NHS values or needs. I would recommend Soar Beyond to other companies seeking to understand, align and service their payer decision-makers in a more meaningful way."
"Having worked with Soar Beyond for many years, it has been fantastic to work closely with them again recently across our business area. We have commissioned Soar Beyond to work on both internal upskilling of our market access teams and external payer support and consultancy. We are particularly excited to be supporting a national pathway redesign programme using the Soar Beyond proprietary 4DTM methodology. From a personal perspective, I can always trust Soar Beyond to really understand my needs, develop effective interventions and always deliver to the highest of standards."
"I have commissioned Soar Beyond for a number of clinical initiatives because they understand the medicines optimisation agenda and the impact it has on patient outcomes. The outcomes of our collaborative projects have demonstrated the return on investment in both financial terms as well as quality and patient improvements."
"Soar Beyond were commissioned by the CCG to provide a practice-focussed Medicines Optimisation Service to deliver evidence-based efficiencies to support QIPP delivery. Soar Beyond developed and implemented a robust plan that delivered the desired outcomes within the agreed time and budget. We found Soar Beyond to be extremely responsive, proactive in their approach and they communicated effectively with practices and the CCG throughout the project."